EXC Exelon Corporation - Fundamental Analysis
BULLISH
EXC Stock | Fundamental Analysis & Investment Insights
NASDAQ
•
Utilities
•
Utilities - Regulated Electric
Current Price
$45.94
Analyst Target
$49.88
+8.6% Upside
52W High
$48.51
52W Low
$35.94
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
88%
Analysis Accuracy
Exelon Corporation (EXC) presents a compelling investment case supported by strong earnings momentum, disciplined capital allocation, and a favorable valuation relative to peers. The company has delivered consistent earnings beats over the past two years, with recent YoY EPS growth of 21.1% and a remarkable Q/Q surge of 120.5%, driven by operational efficiency and regulated revenue stability. Trading at a forward P/E of 17.47, EXC is attractively valued against a sector average of 22.92, while offering a robust 3.48% dividend yield with a sustainable 56.6% payout ratio. Analysts concur with a unanimous buy rating and a $49.88 target price, implying 8.6% upside, further reinforced by solid ROE of 10.31% and improving margin trends.
Key Strengths
Consistent earnings outperformance: 7 of last 8 quarters beat estimates, with an average surprise of 7.85% over the last four
Superior profitability: ROE of 10.31% exceeds sector average of 9.85%, and operating margin of 22.18% reflects strong cost control
Attractive valuation: Forward P/E of 17.47 vs. sector average of 22.92, offering relative value despite stronger growth than peers like DUK and SO
Healthy dividend profile: 3.48% yield with a sustainable 56.6% payout ratio, providing income stability in a low-growth sector
Strong revenue and earnings growth: 9.0% YoY revenue growth and 22.9% YoY earnings growth outpace sector averages of 8.4% and implied peer growth
Key Risks
Elevated leverage: Debt/Equity ratio of 1.78 is above sector average of 1.48 and peer AEP (1.52), increasing refinancing and interest rate risk
Weak liquidity position: Current ratio of 0.94 and quick ratio of 0.61 indicate tight short-term liquidity, below sector health norms
Missing cash flow data: Absence of free cash flow and operating cash flow figures limits visibility into capital distribution sustainability
Valuation data gaps: Missing EV/EBITDA, EV/Revenue, and cash/debt figures hinder comprehensive enterprise-level analysis
Near-term price weakness: 1-month return of -3.1% underperforms peers like AEP (+19.6% 6M) and SRE (+20.4% 6M), signaling relative weakness
AI Fair Value Estimate
Based on comprehensive analysis
$49.88
+8.6% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare EXC against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations